Search Results - "QUASTHOFF, S"

Refine Results
  1. 1

    Secondary myopathy due to systemic diseases by Finsterer, J., Löscher, W. N., Wanschitz, J., Quasthoff, S., Grisold, W.

    Published in Acta neurologica Scandinavica (01-12-2016)
    “…Background Some systemic diseases also affect the skeletal muscle to various degrees and with different manifestations. This review aimed at summarizing and…”
    Get full text
    Journal Article
  2. 2

    Causally treatable, hereditary neuropathies in Fabry's disease, transthyretin‐related familial amyloidosis, and Pompe's disease by Finsterer, J., Wanschitz, J., Quasthoff, S., Iglseder, S., Löscher, W., Grisold, W.

    Published in Acta neurologica Scandinavica (01-12-2017)
    “…Objectives Most acquired neuropathies are treatable, whereas genetic neuropathies respond to treatment in Fabry's disease (FD), transthyretin‐related familial…”
    Get full text
    Journal Article
  3. 3

    Pompe disease in Austria: clinical, genetic and epidemiological aspects by Löscher, W. N., Huemer, M., Stulnig, T. M., Simschitz, P., Iglseder, S., Eggers, C., Moser, H., Möslinger, D., Freilinger, M., Lagler, F., Grinzinger, S., Reichhardt, M., Bittner, R. E., Schmidt, W. M., Lex, U., Brunner-Krainz, M., Quasthoff, S., Wanschitz, J. V.

    Published in Journal of neurology (01-01-2018)
    “…In this study, we performed a survey of infantile and late-onset Pompe disease (IOPD and LOPD) in Austria. Paediatric and neuromuscular centres were contacted…”
    Get full text
    Journal Article
  4. 4

    Consequences of mutations within the C terminus of the FHL1 gene by SCHOSER, B, GOEBEL, H. H, JANISCH, I, QUASTHOFF, S, ROTHER, J, BERGMANN, M, MÜLLER-FELBER, W, WINDPASSINGER, C

    Published in Neurology (18-08-2009)
    “…Mutations in the four-and-a-half LIM domain 1 gene (FHL1) cause X-linked late-onset scapuloaxioperoneal myopathy characterized by postural muscle atrophy with…”
    Get full text
    Journal Article
  5. 5

    The frequency of occurrence of atypical lymphocytes in peripheral blood smears of natalizumab‐treated patients with multiple sclerosis by Robier, C., Amouzadeh‐Ghadikolai, O., Bregant, C., Diez, J., Melinz, K., Quehenberger, F., Quasthoff, S.

    “…Summary Introduction Aside from the extensive published data on immunophenotypic lymphocyte subsets in natalizumab‐treated patients with multiple sclerosis…”
    Get full text
    Journal Article
  6. 6

    The chemotherapeutic oxaliplatin alters voltage-gated Na + channel kinetics on rat sensory neurons by Adelsberger, Helmuth, Quasthoff, Stefan, Grosskreutz, Julian, Lepier, Alexandra, Eckel, Florian, Lersch, Christian

    Published in European journal of pharmacology (06-10-2000)
    “…The chemotherapeutic oxaliplatin causes a sensory-motor neuropathy with predominantly hyperpathic symptoms. The mechanism underlying this hyperexcitability was…”
    Get full text
    Journal Article
  7. 7

    Iatrogenic lesions of peripheral nerves by Löscher, W. N., Wanschitz, J., Iglseder, S., Vass, A., Grinzinger, S., Pöschl, P., Grisold, W., Ninkovic, M., Antoniadis, G., Pedro, M.T., König, R., Quasthoff, S., Oder, W., Finsterer, J.

    Published in Acta neurologica Scandinavica (01-11-2015)
    “…Iatrogenic nerve lesions (INLs) are an integral part of peripheral neurology and require dedicated neurologists to manage them. INLs of peripheral nerves are…”
    Get full text
    Journal Article
  8. 8

    Calcium potentials and tetrodotoxin-resistant sodium potentials in unmyelinated C fibres of biopsied human sural nerve by Quasthoff, S., Grosskreutz, J., Schröder, J.M., Schneider, U., Grafe, P.

    Published in Neuroscience (01-12-1995)
    “…Compound action potentials and electrotonic responses to 150 ms current pulses were recorded from isolated nerve fascicles of human sural nerve biopsies…”
    Get full text
    Journal Article
  9. 9
  10. 10

    A mechanosensitive K+ channel with fast-gating kinetics on human axons blocked by gadolinium ions by Quasthoff, S

    Published in Neuroscience letters (14-03-1994)
    “…Current recordings from single mechanosensitive potassium channels were obtained from cell-attached and excised patches of human axons. The channel showed an…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Capsaicin blocks tetrodotoxin-resistant sodium potentials and calcium potentials in unmyelinated C fibres of biopsied human sural nerve in vitro by Großkreutz, J., Quasthoff, S., Kühn, M., Grafe, P.

    Published in Neuroscience letters (12-04-1996)
    “…Topical application of capsaicin has been tested recently for treatment of painful peripheral neuropathy. In the present study, effects of capsaicin were…”
    Get full text
    Journal Article
  13. 13

    X-linked dominant Charcot-Marie-Tooth disease : nerve biopsies allow morphological evaluation and detection of connexin32 mutations (Arg15Trp, Arg22Gln) by SENDEREK, J, BERGMANN, C, QUASTHOFF, S, RAMAEKERS, V. T, SCHRÖDER, J. M

    Published in Acta neuropathologica (01-05-1998)
    “…X-linked Charcot-Marie-Tooth neuropathy (CMTX) is caused by mutations in the connexin32 gene on Xq13. Because of overlapping morphological and clinical data,…”
    Get full text
    Journal Article Web Resource
  14. 14

    Chemotherapy-induced peripheral neuropathy by QUASTHOFF, Stefan, HARTUNG, Hans Peter

    Published in Journal of neurology (2002)
    “…The induction of peripheral neuropathy is a common factor in limiting therapy with chemotherapeutic drugs. Little is known about the mechanisms responsible for…”
    Get full text
    Journal Article
  15. 15

    Hyperglycaemic hypoxia alters after-potential and fast K+ conductance of rat axons by cytoplasmic acidification by Schneider, U, Quasthoff, S, Mitrović, N, Grafe, P

    Published in The Journal of physiology (01-06-1993)
    “…1. The effects of hyperglycaemic hypoxia (a condition possibly involved in the pathogenesis of diabetic neuropathy) on the depolarizing after-potential and the…”
    Get full text
    Journal Article
  16. 16

    Clinical phase II evaluation of paclitaxel in combination with cisplatin in metastatic or recurrent squamous cell carcinoma of the head and neck by Thodtmann, R., Theiss, F., Kemmerich, M., Heinrich, B., Laubenbacher, C., Quasthoff, S., Kau, R., Herzog, M., Diergarten, K., Hanauske, A.-R.

    Published in Annals of oncology (01-03-1998)
    “…Background: Paclitaxel as single agent has shown marked activity in several malignancies. The aim of the present phase II trial was to determine the activity…”
    Get full text
    Journal Article
  17. 17

    Sodium channel inactivation kinetics of rat sensory and motor nerve fibres and their modulation by glutathione by Mitrović, N, Quasthoff, S, Grafe, P

    Published in Pflügers Archiv (01-12-1993)
    “…Na+ channel currents of rat motor and sensory nerve fibres were studied with the patch-clamp technique on enzymatically demyelinated axons. Differences between…”
    Get full text
    Journal Article
  18. 18

    Clinical aspects and molecular basis of oxaliplatin neurotoxicity: Current management and development of preventive measures by Gamelin, Erick, Gamelin, Laurence, Bossi, Laura, Quasthoff, Stefan

    Published in Seminars in oncology (01-10-2002)
    “…Neurotoxicity is the most frequent dose-limiting toxicity of oxaliplatin. Acute neurotoxicity is characterized by the rapid onset of cold-induced distal…”
    Get full text
    Journal Article
  19. 19
  20. 20